<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>colesevelam</title><link>http://www.unboundmedicine.com/medline/ebm/research/colesevelam</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19879973/full_citation/Effects_of_chenodeoxycholate_and_a_bile_acid_sequestrant_colesevelam_on_intestinal_transit_and_bowel_function_</link><description>Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, et al. <br/><span class="title">Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association">Clin Gastroenterol Hepatol 2009 Oct 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19879973/abstract/Effects_of_chenodeoxycholate_and_a_bile_acid_sequestrant_colesevelam_on_intestinal_transit_and_bowel_function_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19879973/full_citation/Effects_of_chenodeoxycholate_and_a_bile_acid_sequestrant_colesevelam_on_intestinal_transit_and_bowel_function_">Full Citation</a></description></item><item><title>Colesevelam Hydrochloride: Efficacy and Safety in Pediatric Subjects with Heterozygous Familial Hypercholesterolemia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19879596/full_citation/Colesevelam_Hydrochloride:_Efficacy_and_Safety_in_Pediatric_Subjects_with_Heterozygous_Familial_Hypercholesterolemia_</link><description>Stein EA, Marais AD, Szamosi T, et al. <br/><span class="title">Colesevelam Hydrochloride: Efficacy and Safety in Pediatric Subjects with Heterozygous Familial Hypercholesterolemia. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of pediatrics">J Pediatr 2009 Oct 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19879596/abstract/Colesevelam_Hydrochloride:_Efficacy_and_Safety_in_Pediatric_Subjects_with_Heterozygous_Familial_Hypercholesterolemia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19879596/full_citation/Colesevelam_Hydrochloride:_Efficacy_and_Safety_in_Pediatric_Subjects_with_Heterozygous_Familial_Hypercholesterolemia_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0022-3476(09)00804-X">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19879596/Colesevelam_Hydrochloride:_Efficacy_and_Safety_in_Pediatric_Subjects_with_Heterozygous_Familial_Hypercholesterolemia_">Find Related Articles</a> </description></item><item><title>Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19862667/full_citation/Long_term_Safety_and_Tolerability_of_Colesevelam_HCl_in_Subjects_with_Type_2_Diabetes_</link><description>Goldfine AB, Fonseca VA, Jones MR, et al. <br/><span class="title">Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes. [JOURNAL ARTICLE]</span><br/><span class="source" title="Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme">Horm Metab Res 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19862667/abstract/Long_term_Safety_and_Tolerability_of_Colesevelam_HCl_in_Subjects_with_Type_2_Diabetes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19862667/full_citation/Long_term_Safety_and_Tolerability_of_Colesevelam_HCl_in_Subjects_with_Type_2_Diabetes_">Full Citation</a></description></item><item><title>Advances in the Treatment of Type 2 Diabetes Mellitus.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19834322/full_citation/Advances_in_the_Treatment_of_Type_2_Diabetes_Mellitus_</link><description>Israili ZH <br/><span class="title">Advances in the Treatment of Type 2 Diabetes Mellitus. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of therapeutics">Am J Ther 2009 Oct 14.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19834322/abstract/Advances_in_the_Treatment_of_Type_2_Diabetes_Mellitus_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19834322/full_citation/Advances_in_the_Treatment_of_Type_2_Diabetes_Mellitus_">Full Citation</a></description></item><item><title>A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19793501/full_citation/A_new_use_for_an_old_drug_provides_dual_glucose_and_LDL_lowering_therapy_in_the_modern_setting_of_T2D_management:_colesevelam_HCL_</link><description>Goldberg RB <br/><span class="title">A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL. [Journal Article]</span><br/><span class="source" title="Current diabetes reports">Curr Diab Rep 2009 Oct; 9(5):331-2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19793501/full_citation/A_new_use_for_an_old_drug_provides_dual_glucose_and_LDL_lowering_therapy_in_the_modern_setting_of_T2D_management:_colesevelam_HCL_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19793501/A_new_use_for_an_old_drug_provides_dual_glucose_and_LDL_lowering_therapy_in_the_modern_setting_of_T2D_management:_colesevelam_HCL_">Find Related Articles</a> </description></item><item><title>Effect of the Bile Acid Sequestrant Colesevelam on the Pharmacokinetics of Pioglitazone, Repaglinide, Estrogen Estradiol, Norethindrone, Levothyroxine, and Glyburide.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19789374/full_citation/Effect_of_the_Bile_Acid_Sequestrant_Colesevelam_on_the_Pharmacokinetics_of_Pioglitazone_Repaglinide_Estrogen_Estradiol_Norethindrone_Levothyroxine_and_Glyburide_</link><description>Brown KS, Armstrong IC, Wang A, et al. <br/><span class="title">Effect of the Bile Acid Sequestrant Colesevelam on the Pharmacokinetics of Pioglitazone, Repaglinide, Estrogen Estradiol, Norethindrone, Levothyroxine, and Glyburide. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical pharmacology">J Clin Pharmacol 2009 Sep 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19789374/abstract/Effect_of_the_Bile_Acid_Sequestrant_Colesevelam_on_the_Pharmacokinetics_of_Pioglitazone_Repaglinide_Estrogen_Estradiol_Norethindrone_Levothyroxine_and_Glyburide_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19789374/full_citation/Effect_of_the_Bile_Acid_Sequestrant_Colesevelam_on_the_Pharmacokinetics_of_Pioglitazone_Repaglinide_Estrogen_Estradiol_Norethindrone_Levothyroxine_and_Glyburide_">Full Citation</a></description></item><item><title>Effects of Colesevelam HCl, Rosiglitazone, or Sitagliptin on Glycemic Control and the Lipid Profile in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19789153/full_citation/Effects_of_Colesevelam_HCl_Rosiglitazone_or_Sitagliptin_on_Glycemic_Control_and_the_Lipid_Profile_in_Subjects_With_Type_2_Diabetes_Inadequately_Controlled_on_Metformin_Monotherapy_</link><description>Rigby SP, Handelsman Y, Lai YL, et al. <br/><span class="title">Effects of Colesevelam HCl, Rosiglitazone, or Sitagliptin on Glycemic Control and the Lipid Profile in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists">Endocr Pract 2009 Sep 28.:1-34.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19789153/abstract/Effects_of_Colesevelam_HCl_Rosiglitazone_or_Sitagliptin_on_Glycemic_Control_and_the_Lipid_Profile_in_Subjects_With_Type_2_Diabetes_Inadequately_Controlled_on_Metformin_Monotherapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19789153/full_citation/Effects_of_Colesevelam_HCl_Rosiglitazone_or_Sitagliptin_on_Glycemic_Control_and_the_Lipid_Profile_in_Subjects_With_Type_2_Diabetes_Inadequately_Controlled_on_Metformin_Monotherapy_">Full Citation</a></description></item><item><title>Rediscovering bile acid sequestrants.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19788434/full_citation/Rediscovering_bile_acid_sequestrants_</link><description>Bell DS, O'Keefe JH <br/><span class="title">Rediscovering bile acid sequestrants. [JOURNAL ARTICLE]</span><br/><span class="source" title="Diabetes, obesity &amp; metabolism">Diabetes Obes Metab 2009 Sep 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19788434/abstract/Rediscovering_bile_acid_sequestrants_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19788434/full_citation/Rediscovering_bile_acid_sequestrants_">Full Citation</a></description></item><item><title>Quantitative structure-property relationships modeling to predict in vitro and in vivo binding of drugs to the bile sequestrant, colesevelam (welchol).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19783712/full_citation/Quantitative_structure_property_relationships_modeling_to_predict_in_vitro_and_in_vivo_binding_of_drugs_to_the_bile_sequestrant_colesevelam__welchol__</link><description>Walker JR, Brown K, Rohatagi S, et al. <br/><span class="title">Quantitative structure-property relationships modeling to predict in vitro and in vivo binding of drugs to the bile sequestrant, colesevelam (welchol). [Journal Article]</span><br/><span class="source" title="Journal of clinical pharmacology">J Clin Pharmacol 2009 Oct; 49(10):1185-95.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19783712/abstract/Quantitative_structure_property_relationships_modeling_to_predict_in_vitro_and_in_vivo_binding_of_drugs_to_the_bile_sequestrant_colesevelam__welchol__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19783712/full_citation/Quantitative_structure_property_relationships_modeling_to_predict_in_vitro_and_in_vivo_binding_of_drugs_to_the_bile_sequestrant_colesevelam__welchol__">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19783712/Quantitative_structure_property_relationships_modeling_to_predict_in_vitro_and_in_vivo_binding_of_drugs_to_the_bile_sequestrant_colesevelam__welchol__">Find Related Articles</a> </description></item><item><title>Combined therapy in the treatment of dyslipidemia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19682080/full_citation/Combined_therapy_in_the_treatment_of_dyslipidemia_</link><description>Reiner Z <br/><span class="title">Combined therapy in the treatment of dyslipidemia. [JOURNAL ARTICLE]</span><br/><span class="source" title="Fundamental &amp; clinical pharmacology">Fundam Clin Pharmacol 2009 Aug 14.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19682080/abstract/Combined_therapy_in_the_treatment_of_dyslipidemia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19682080/full_citation/Combined_therapy_in_the_treatment_of_dyslipidemia_">Full Citation</a></description></item></channel></rss>